Interventions To Prevent Work-Related Stress and Support Health Worker Mental Health; Request for Information, 53306-53308 [2021-20931]
Download as PDF
<![CDATA[
53306
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
the U. S. (OMB Control No. 0920–0338,
Exp. 4/30/2022)—Extension—National
Center for Chronic Disease and Public
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are
associated with many health problems.
Using smokeless tobacco: Can lead to
nicotine addiction; causes cancer of the
mouth, esophagus, and pancreas; is
associated with diseases of the mouth;
can increase risks for early delivery and
required information to CDC through a
designated representative. The
information collection is subject to strict
confidentiality provisions.
Ingredient and nicotine analysis
reports for new SLT products are due at
the time of first importation. Thereafter,
ingredient reports are due annually on
March 31. Information is submitted to
CDC by mailing a written report on the
respondent’s letterhead. Electronic mail
submissions are not accepted. Annual
submission reports are mailed to
Attention: FCLAA Program Manager,
Office on Smoking and Health, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway NE, MS S107–7,
Atlanta, GA 30341–3717.
Following receipt of the annual
nicotine and ingredient report, CDC
issues a Certificate of Compliance to the
respondent. As deemed appropriate by
the Secretary of HHS, HHS is authorized
to use the information to report to
Congress the health effects of
ingredients, research activities related to
the health effects of ingredients, and
other information that the Secretary
determines to be of public interest.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
18,843. OMB approval is requested for
three years.
stillbirth when used during pregnancy;
can cause nicotine poisoning in
children; and may increase the risk for
death from heart disease and stroke.
The CDC’s Office on Smoking and
Health (OSH) is the lead federal agency
for comprehensive tobacco prevention
and control. As required by the
Comprehensive Smokeless Tobacco
Health Education Act of 1986 (CSTHEA,
15 U.S.C. 4401 et seq., Pub. L. 99–252),
CDC collects a list of ingredients added
to tobacco in the manufacture of
smokeless tobacco products and a
specification of the quantity of nicotine
contained in each product. HHS has
delegated responsibility for
implementing the required information
collection to CDC’s OSH. Respondents
are manufacturers, packagers, or
importers (or their representatives) of
smokeless tobacco products.
Respondents are not required to submit
specific forms; however, they are
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies that are
required to report ingredients added to
other consumer products, and to report
on the quantity of nicotine contained in
each smokeless tobacco product as
specified in previous Federal Register
Notices. Respondents may submit the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Smokeless Tobacco Manufacturers, Packagers, and Importers.
Smokeless Tobacco Manufacturers, Packagers, and Importers.
SLT Ingredient Report .............
11
1
6.5
71.5
SLT Nicotine Data Reporting ..
11
1
1,706.5
18,771.5
Total ....................................................
..................................................
........................
........................
........................
18,843
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–20845 Filed 9–24–21; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[Docket No. CDC–2021–0106; NIOSH–344]
Interventions To Prevent Work-Related
Stress and Support Health Worker
Mental Health; Request for Information
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
Centers for Disease Control and
Prevention, HHS.
ACTION: Request for information.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH), within the Centers for Disease
SUMMARY:
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Control and Prevention (CDC),
announces an opportunity for the public
to provide information and comments
on current evidence-based, workplace
and occupational safety and health
interventions to prevent workassociated stress, support stress
reduction, and foster positive mental
health and well-being among the
nation’s health workers. Information
and comments are also requested on
interventions under development and
research in progress to support and
promote the mental health and wellbeing of health workers. NIOSH is
seeking information on related best
practices, promising practices, or
E:\FR\FM\27SEN1.SGM
27SEN1
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
successful programs related to providing
stress prevention and mental health
services to health workers. Examples of
such services include, but are not
limited to, employee assistance
programs, screenings, supervisor
trainings, workplace policies, talk
therapy, mindfulness, peer support, and
mobile apps.
DATES: Comments must be received by
November 26, 2021.
ADDRESSES: Comments may be
submitted through either of the
following two methods:
• Federal eRulemaking Portal: https://
www.regulations.gov (follow the
instructions for submitting comments),
or
• By Mail: NIOSH Docket Office,
Robert A. Taft Laboratories, MS C–34,
1090 Tusculum Avenue, Cincinnati,
Ohio 45226–1998.
Instructions: All written submissions
received in response to this notice must
include the agency name (Centers for
Disease Control and Prevention, HHS)
and docket number (CDC–2021–0106;
NIOSH–344) for this action. All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
lotter on DSK11XQN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Rachel Weiss, Program Analyst; 1090
Tusculum Ave., MS: C–48, Cincinnati,
OH 45226; telephone (855) 818–1629
(this is a toll-free number); email
NIOSHregs@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Centers for Disease Control and
Prevention (CDC) is charged by the
American Rescue Plan Act of 2021 (Pub.
L. 117–2, sec. 2704) with educating
health workers and first responders on
primary prevention of mental health
conditions and substance use disorders
and encouraging these professionals to
identify and seek support for their own
mental health or substance use
concerns. Accordingly, CDC’s National
Institute for Occupational Safety and
Health (NIOSH) announces an
opportunity for the public to provide
information and comments on evidencebased workplace and occupational
safety and health interventions, policies,
or other activities relevant to health care
professionals and first responders,
including those at the population,
organizational, or individual levels.
Information and comments are
requested on related interventions
under development and research in
progress. NIOSH is also seeking
information on related best practices,
promising practices, or successful
programs related to providing stress
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
prevention and mental health services
to health workers.
Health workers include everyone who
works in healthcare—for public and
private providers, in clinical and
community settings—such as first
responders, admitting and ward clerks,
laboratory technologists and
technicians, nurses, physicians,
environmental services workers, and
food service staff in healthcare settings.
Health workers face many demands at
work, which may include difficult
working conditions, long work hours,
rotating and irregular shifts, exposure to
human suffering and death, and
increased risks for personal exposure to
disease and harm.1 The COVID–19
pandemic has exacerbated these
challenges and contributed to new and
worsening mental health concerns,
including burnout, compassion fatigue,
depression, anxiety, substance use
disorders, and suicidal ideation. These
concerns, in turn, can affect workers’
overall health, job performance, and
patient care and safety.2
Many lower-paid or part-time health
workers—such as home health aides,
orderlies, medical assistants,
phlebotomists, and pharmacy aides—
may have experienced barriers
preventing access to health care services
and information, including financial
challenges, lack of health insurance
coverage, or lack of adequate
transportation. They can also face lack
of recognition and civility (including
threatened and actual workplace
violence) for the important work they
do. Even health workers who are not on
the frontlines or at high risk of infection
may still encounter work demands that
cause poor mental health outcomes.3
Public health workers are also at
increased risk for negative mental health
consequences when responding to
public health emergencies, such as the
COVID–19 pandemic, where they must
operate under high-stakes conditions for
extended periods of time without
relief.4
1 National Occupational Research Agenda
(NORA) Healthcare and Social Assistance Council.
National Occupational Research Agenda for
Healthcare and Social Assistance (HCSA). February
2019. https://www.cdc.gov/nora/councils/hcsa/
pdfs/National_Occpational_Agenda_for_HCSA_
February_2019-508.pdf.
2 National Academy of Medicine. Strategies to
Support the Health and Well-Being of Clinicians
during the COVID–19 Outbreak. https://nam.edu/
initiatives/clinician-resilience-and-well-being/
clinician-well-being-strategies-during-covid-19/.
3 See supra note 1.
4 Bryant-Genevier J, Rao CY, Lopes-Cardozo B, et
al. Symptoms of Depression, Anxiety, PostTraumatic Stress Disorder, and Suicidal Ideation
Among State, Tribal, Local, and Territorial Public
Health Workers During the COVID–19 Pandemic —
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
53307
NIOSH is interested in receiving
comments and other relevant, evidencebased information from a variety of
partners, including employers, labor
unions, workers, researchers, treatment
providers, and government agencies at
all levels (Federal, State, Territorial,
local, and Tribal). Information provided,
including narrative evidence, data, or
anecdotes, will support nation-wide
efforts to raise awareness of mental
health concerns, identify best practices
to prevent and reduce work stress and
related adverse mental health outcomes,
identify workplace and community
supports, and reduce stigma related to
seeking and receiving care. NIOSH may
use the information provided to
assimilate the best available evidence;
develop a repository of best practices,
resources, and interventions; identify
and adapt tools; improve data and
surveillance; and develop trainings and
resources to inform and support
employer policy change. NIOSH will
also generate awareness by conducting a
national social marketing campaign to
provide tools and resources to
employers, normalize the conversation
around mental health, and lower
barriers for health workers seeking care
for mental health.
Commenters are not required to
respond to the questions below and may
respond to as many or few as desired.
While all inputs are welcomed,
comments addressing the following
questions are especially helpful:
Questions for Workplaces With
Interventions and Services in Place
1. Please tell us about your experience
with the development of any preventive
interventions currently in place in your
workplace to help health workers avoid
work-related stress and maintain or
improve their mental health and wellbeing. Describe the intervention’s
origins and basis, its target population,
evaluation or outcome measures,
challenges and successes, as well as any
other information you think is
noteworthy.
2. Please tell us about your experience
with the development of any diagnostic
and/or therapeutic services offered in
your workplace by the employer or
union to health workers who are
experiencing stress or difficulties with
their mental health and well-being.
Describe the services’ origins and bases,
their target population, evaluation or
outcome measures, challenges and
successes, as well as any other
information you think is noteworthy.
United States, March–April 2021. MMWR Morb
Mortal Wkly Rep 2021;70:947–952.
E:\FR\FM\27SEN1.SGM
27SEN1
53308
Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices
3. For both preventive interventions
and diagnostic/treatment services in
your workplace, please describe how
widely the services are used, how
stigma associated with seeking mental
health care is addressed, and how
health workers are encouraged to
participate. In your experience, how
does the workplace benefit from
implementing interventions or offering
services to health workers to prevent/
reduce work-related stress, to decrease
stigma related to seeking and receiving
care, and to improve the mental health
and well-being of health workers?
4. Please describe any programs you
are aware of that help employers to fund
or otherwise develop interventions or
services to support health worker
mental health and well-being.
Questions About Workplaces
5. Please tell us about your experience
with any workplace policies designed to
protect workers from stress and adverse
mental health outcomes and to address
these issues. Describe the part(s) of your
organization involved in workassociated stress prevention efforts.
lotter on DSK11XQN23PROD with NOTICES1
Questions About Health Workers’
Communication Preferences
6. Please tell us about your
workplace’s most effective methods of
informing health workers about
available interventions, services, and
workplace practices and policies,
including but not limited to:
Notification channels, trusted
messengers (e.g., upper management,
front line supervisor, union
representatives), and efforts to reach
workers who are underserved by mental
health/behavioral health resources.
7. In your experience, do workers seek
mental health and well-being
information outside the workplace and,
if so, where (e.g., community-based,
faith-based)? Do health workers
generally find sources of information
outside the workplace more trustworthy
and credible than employer-based
programs? If so, what is the basis for this
understanding and what efforts have
you undertaken to address such
concerns?
In addition to the specific questions
above, NIOSH would also like to hear
from researchers currently conducting
research on stress, burnout, and other
VerDate Sep<11>2014
18:08 Sep 24, 2021
Jkt 253001
mental health and well-being concerns
among a broad range of health workers.
John J. Howard,
Administrator, World Trade Center Health
Program and Director, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention, Department
of Health and Human Services.
[FR Doc. 2021–20931 Filed 9–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0210; Docket No. CDC–2021–
0102]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
continuing information collection
project titled List of Ingredients Added
to Tobacco in the Manufacture of
Cigarette Products. The proposed
collection allows CDC’s Office of
Smoking and Health (OSH) to collect
information about the ingredients used
in cigarette products, a responsibility
that has been delegated to CDC by HHS.
DATES: CDC must receive written
comments on or before November 26,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0102 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
Proposed Project
List of Ingredients Added to Tobacco
in the Manufacture of Cigarette Products
(OMB Control No. 0920–0210, Exp.
4/30/2022)—Extension—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53306-53308]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20931]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0106; NIOSH-344]
Interventions To Prevent Work-Related Stress and Support Health
Worker Mental Health; Request for Information
AGENCY: Centers for Disease Control and Prevention, HHS.
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH), within the Centers for Disease Control and Prevention (CDC),
announces an opportunity for the public to provide information and
comments on current evidence-based, workplace and occupational safety
and health interventions to prevent work-associated stress, support
stress reduction, and foster positive mental health and well-being
among the nation's health workers. Information and comments are also
requested on interventions under development and research in progress
to support and promote the mental health and well-being of health
workers. NIOSH is seeking information on related best practices,
promising practices, or
[[Page 53307]]
successful programs related to providing stress prevention and mental
health services to health workers. Examples of such services include,
but are not limited to, employee assistance programs, screenings,
supervisor trainings, workplace policies, talk therapy, mindfulness,
peer support, and mobile apps.
DATES: Comments must be received by November 26, 2021.
ADDRESSES: Comments may be submitted through either of the following
two methods:
Federal eRulemaking Portal: https://www.regulations.gov
(follow the instructions for submitting comments), or
By Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS C-34, 1090 Tusculum Avenue, Cincinnati, Ohio 45226-1998.
Instructions: All written submissions received in response to this
notice must include the agency name (Centers for Disease Control and
Prevention, HHS) and docket number (CDC-2021-0106; NIOSH-344) for this
action. All relevant comments, including any personal information
provided, will be posted without change to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Rachel Weiss, Program Analyst; 1090
Tusculum Ave., MS: C-48, Cincinnati, OH 45226; telephone (855) 818-1629
(this is a toll-free number); email [email protected].
SUPPLEMENTARY INFORMATION: The Centers for Disease Control and
Prevention (CDC) is charged by the American Rescue Plan Act of 2021
(Pub. L. 117-2, sec. 2704) with educating health workers and first
responders on primary prevention of mental health conditions and
substance use disorders and encouraging these professionals to identify
and seek support for their own mental health or substance use concerns.
Accordingly, CDC's National Institute for Occupational Safety and
Health (NIOSH) announces an opportunity for the public to provide
information and comments on evidence-based workplace and occupational
safety and health interventions, policies, or other activities relevant
to health care professionals and first responders, including those at
the population, organizational, or individual levels. Information and
comments are requested on related interventions under development and
research in progress. NIOSH is also seeking information on related best
practices, promising practices, or successful programs related to
providing stress prevention and mental health services to health
workers.
Health workers include everyone who works in healthcare--for public
and private providers, in clinical and community settings--such as
first responders, admitting and ward clerks, laboratory technologists
and technicians, nurses, physicians, environmental services workers,
and food service staff in healthcare settings. Health workers face many
demands at work, which may include difficult working conditions, long
work hours, rotating and irregular shifts, exposure to human suffering
and death, and increased risks for personal exposure to disease and
harm.\1\ The COVID-19 pandemic has exacerbated these challenges and
contributed to new and worsening mental health concerns, including
burnout, compassion fatigue, depression, anxiety, substance use
disorders, and suicidal ideation. These concerns, in turn, can affect
workers' overall health, job performance, and patient care and
safety.\2\
---------------------------------------------------------------------------
\1\ National Occupational Research Agenda (NORA) Healthcare and
Social Assistance Council. National Occupational Research Agenda for
Healthcare and Social Assistance (HCSA). February 2019. https://www.cdc.gov/nora/councils/hcsa/pdfs/National_Occpational_Agenda_for_HCSA_February_2019-508.pdf.
\2\ National Academy of Medicine. Strategies to Support the
Health and Well-Being of Clinicians during the COVID-19 Outbreak.
https://nam.edu/initiatives/clinician-resilience-and-well-being/clinician-well-being-strategies-during-covid-19/.
---------------------------------------------------------------------------
Many lower-paid or part-time health workers--such as home health
aides, orderlies, medical assistants, phlebotomists, and pharmacy
aides--may have experienced barriers preventing access to health care
services and information, including financial challenges, lack of
health insurance coverage, or lack of adequate transportation. They can
also face lack of recognition and civility (including threatened and
actual workplace violence) for the important work they do. Even health
workers who are not on the frontlines or at high risk of infection may
still encounter work demands that cause poor mental health outcomes.\3\
---------------------------------------------------------------------------
\3\ See supra note 1.
---------------------------------------------------------------------------
Public health workers are also at increased risk for negative
mental health consequences when responding to public health
emergencies, such as the COVID-19 pandemic, where they must operate
under high-stakes conditions for extended periods of time without
relief.\4\
---------------------------------------------------------------------------
\4\ Bryant-Genevier J, Rao CY, Lopes-Cardozo B, et al. Symptoms
of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal
Ideation Among State, Tribal, Local, and Territorial Public Health
Workers During the COVID-19 Pandemic -- United States, March-April
2021. MMWR Morb Mortal Wkly Rep 2021;70:947-952.
---------------------------------------------------------------------------
NIOSH is interested in receiving comments and other relevant,
evidence-based information from a variety of partners, including
employers, labor unions, workers, researchers, treatment providers, and
government agencies at all levels (Federal, State, Territorial, local,
and Tribal). Information provided, including narrative evidence, data,
or anecdotes, will support nation-wide efforts to raise awareness of
mental health concerns, identify best practices to prevent and reduce
work stress and related adverse mental health outcomes, identify
workplace and community supports, and reduce stigma related to seeking
and receiving care. NIOSH may use the information provided to
assimilate the best available evidence; develop a repository of best
practices, resources, and interventions; identify and adapt tools;
improve data and surveillance; and develop trainings and resources to
inform and support employer policy change. NIOSH will also generate
awareness by conducting a national social marketing campaign to provide
tools and resources to employers, normalize the conversation around
mental health, and lower barriers for health workers seeking care for
mental health.
Commenters are not required to respond to the questions below and
may respond to as many or few as desired. While all inputs are
welcomed, comments addressing the following questions are especially
helpful:
Questions for Workplaces With Interventions and Services in Place
1. Please tell us about your experience with the development of any
preventive interventions currently in place in your workplace to help
health workers avoid work-related stress and maintain or improve their
mental health and well-being. Describe the intervention's origins and
basis, its target population, evaluation or outcome measures,
challenges and successes, as well as any other information you think is
noteworthy.
2. Please tell us about your experience with the development of any
diagnostic and/or therapeutic services offered in your workplace by the
employer or union to health workers who are experiencing stress or
difficulties with their mental health and well-being. Describe the
services' origins and bases, their target population, evaluation or
outcome measures, challenges and successes, as well as any other
information you think is noteworthy.
[[Page 53308]]
3. For both preventive interventions and diagnostic/treatment
services in your workplace, please describe how widely the services are
used, how stigma associated with seeking mental health care is
addressed, and how health workers are encouraged to participate. In
your experience, how does the workplace benefit from implementing
interventions or offering services to health workers to prevent/reduce
work-related stress, to decrease stigma related to seeking and
receiving care, and to improve the mental health and well-being of
health workers?
4. Please describe any programs you are aware of that help
employers to fund or otherwise develop interventions or services to
support health worker mental health and well-being.
Questions About Workplaces
5. Please tell us about your experience with any workplace policies
designed to protect workers from stress and adverse mental health
outcomes and to address these issues. Describe the part(s) of your
organization involved in work-associated stress prevention efforts.
Questions About Health Workers' Communication Preferences
6. Please tell us about your workplace's most effective methods of
informing health workers about available interventions, services, and
workplace practices and policies, including but not limited to:
Notification channels, trusted messengers (e.g., upper management,
front line supervisor, union representatives), and efforts to reach
workers who are underserved by mental health/behavioral health
resources.
7. In your experience, do workers seek mental health and well-being
information outside the workplace and, if so, where (e.g., community-
based, faith-based)? Do health workers generally find sources of
information outside the workplace more trustworthy and credible than
employer-based programs? If so, what is the basis for this
understanding and what efforts have you undertaken to address such
concerns?
In addition to the specific questions above, NIOSH would also like
to hear from researchers currently conducting research on stress,
burnout, and other mental health and well-being concerns among a broad
range of health workers.
John J. Howard,
Administrator, World Trade Center Health Program and Director, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, Department of Health and Human Services.
[FR Doc. 2021-20931 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P
